Back
CVS Health Quote, Financials, Valuation and Earnings
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
CVS
CVS Health
Last Price:
58.42
Seasonality Move:
-2.22%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmCVS Health Price Quote
$58.42
CVS Health Key Stats
Sell
49
CVS Health (CVS)
is a Sell
Day range:
$57.75 - $59.19
52-week range:
$52.77 - $83.25
Dividend yield:
4.45%
P/E ratio:
9.03
P/S ratio:
0.21
P/B ratio:
0.98%
Volume:
5M
Avg. volume:
8M
1-year change:
-17.37%
Market cap:
$73.5B
Revenue:
$357.8B
EPS:
$5.62
How Much Does CVS Health Make?
-
How Much Are CVS Health's Sales Annually?
CVS Revenues are $357.8B -
How Much Profit Does CVS Health's Make A Year?
CVS net income is $8.3B
Is CVS Health Growing As A Company?
-
What Is CVS Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.03% -
What Is CVS Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.05%
CVS Health Stock Price Performance
-
Did CVS Health Stock Go Up Last Month?
CVS Health share price went up by 0.12% last month -
Did CVS's Share Price Rise Over The Last Year?
CVS share price fell by -17.37% over the past 1 year
What Is CVS Health 52-Week High & Low?
-
What Is CVS Health’s 52-Week High Share Price?
CVS Health has traded as high as $83.25 over the past 52 weeks -
What Is CVS Health’s 52-Week Low Share Price?
CVS Health has traded as low as $52.77 over the past 52 weeks
CVS Health Price To Free Cash Flow
-
Is CVS Health Stock Overvalued?
CVS Health is trading at a price to free cash flow ratio of 14.15 -
Is CVS Health Stock Undervalued?
CVS Health EV to Free Cash Flow ratio is 23.48 -
What Is CVS Health’s Price Earnings Growth Ratio?
CVS PEG ratio is 0.07 -
Is CVS Health Trading At A Premium To Earnings?
CVS Health EV to EBIT ratio is 9.93
Is It Risky To Buy CVS Health?
-
How Much Debt Does CVS Health Have?
Total long term debt quarterly is $66.4B -
How Much Cash Does CVS Health Have?
Cash and short term investments quarterly total is $16.3B -
What Is CVS Health’s Book Value Per Share?
Book value per share is 59.66
Is CVS Health Cash Flow Positive?
-
What Is CVS Cash Flow From Operations?
Cash flow from operations (TTM) is $8.1B -
What Is CVS Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$3.6B -
What Is CVS Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.7B
CVS Health Return On Invested Capital
-
Is Management Doing A Good Job?
CVS return on invested capital is 5.2% -
What Is CVS Health Return On Assets?
ROA measures how assets are converting to revenues and is 2.87% -
What Is CVS Return On Equity?
ROE is a measure of profitability and is 9.63%
CVS Health Earnings Date & Stock Price
-
What Is CVS Health's Stock Price Today?
A single share of CVS can be purchased today for 58.42 -
What Is CVS Health’s Stock Symbol?
CVS Health trades on the S&P500 under the ticker symbol: CVS -
When Is CVS Health’s Next Earnings Date?
The next quarterly earnings date for CVS Health is scheduled on November 1, 2024 -
When Is CVS's next ex-dividend date?
CVS Health's next ex-dividend date is July 22, 2024 -
How To Buy CVS Health Stock?
You can buy CVS Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CVS Health Competitors
-
Who Are CVS Health's Competitors?
Below is a list of companies who compete with CVS Health or are related in some way:
CVS Health Dividend Yield
-
What Is CVS Dividend Yield?
CVS Health’s dividend yield currently is 4.45% -
What Is CVS Health’s Payout Ratio?
CVS Health’s payout ratio is 45.29% -
When Did CVS Health Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is CVS Health’s Dividend Per Share?
CVS Health pays a dividend of $0.67 per share
CVS Health Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -4.73% | 5.95% |
| Revenue: | 2.6% | -0.22% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 15 |
| Sell Recommendations: | 0 |
| Price Target: | 66.15 |
| Upside from Last Price: | 13.23% |